MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterised by amyloid-β accumulation (β-amyloid or senile plaques), formation of hyperphosphorylated tau neurofibrillary tangles, neuroinflammation, synaptic demise, neuronal death and brain dysfunction leading to severe cognitive impairment.